Skip to main content
L

Not yet reviewed: this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

Mexedrone

Mexedrone molecule structureMexedrone molecule structure
3-Methoxy-2-(methylamino)-1-(p-tolyl)propan-1-one
4-MMC-MeOOpen in Piru
Psychoactive Class

Mexedrone is a synthetic substituted cathinone1 described as a stimulant and entactogen, although anecdotal reports suggest that its effects are often mild or absent. It is closely related to mephedrone, with an additional methoxy group,1 and is reported to be substantially less potent. It appeared on the research chemical market in August 2015,1 with little documented human use before its release.

Dosage & Duration

Log in Piru

Dosage

Doses are population estimates that vary widely between individuals.

Threshold~50 mg
Light50-80 mg
Moderate80-120 mg
Strong120-200 mg
Heavy200+ mg

Duration

Onset5 minutes
Total3 hours

Subjective Effects

Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.

Effects vary widely by individual, dose, and context.

Forked from Subjective Effect Documentation work byJosie Kins August 2016.

Reagent Testing

Expected colorimetric results for common reagent tests. Colors show reaction change over 1–2 minutes.

Mandelin(MD)
yellow2 → orange2 → red2 → brown2 → yellow2
Liebermann(LB)
white → yellow1 → orange1
Simons(SI)
orange1 → black2 → blue1 → blue2
Zimm(ZI)
white → brown2
Powered by PROtestkit.eu

Pharmacology

Pharmacodynamics

Mexedrone weakly inhibits the reuptake of serotonin, norepinephrine, and dopamine. It also acts as a weak serotonin releasing agent1, increasing serotonin availability through both release and reduced reuptake.

Pharmacokinetics

Absorption & half-lifenot documented yetMetabolitesnone documented yet

Interactions

Dangerous

Highest risk

These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.

5-HTPAlcoholCocaineDXMDissociativesMAOIsMDMAMXENBOMe compoundsSNRIsSSRIsSerotonin releasersStimulantsTramadol
Powered by TripSit

Tolerance

Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.

Full Tolerance
Prolonged, repeated use of mexedrone produces tolerance to many of its effects, requiring larger doses to achieve the same effects.
Baseline Reset
Tolerance returns to baseline in approximately 1–2 weeks without further use.
Half Tolerance
Tolerance falls to approximately half within 3–7 days without further use.
Cross Tolerance

All dopaminergic stimulants

Harm Potential

Addiction & Dependence

Psychological

Moderate

Chronic mexedrone use is moderately addictive, with high abuse potential and psychological dependence in some users. Once addiction develops, stopping use abruptly may cause cravings.

Physical

Withdrawal effects may occur after abrupt discontinuation in users who have developed addiction.

Toxicity

Lethal Dosage

The exact toxic dose of mexedrone is unknown.

History & Culture

Mexedrone had little to no documented history of human use before its release in August 2015 as a research chemical. It was sold online as a designer drug and primarily marketed as a legal alternative to mephedrone. It may have been developed in response to another mephedrone derivative,…

Legality

By Country

Illegal2
Sweden flagSwedenMexedrone is illegal
Switzerland flagSwitzerlandIllegal

References

Source Pages

  1. Bluelight: Mexedrone Discussion Thread
  2. Drug Users Bible by Dominic Milton Trott
  3. Isomer Design (TiHKAL/PiHKAL)
  4. PsychonautWiki
  5. TripSit Factsheets
  6. Wikipedia

Citations

Further Reading

  1. Roberts et al. (2017) - 11 analytically confirmed cases of mexedrone use among polydrug users
  2. WEDINOS Mexedrone Sample Analysis
  3. Camuto et al. 2021 - In vitro metabolic profile of mexedrone, a mephedrone analog, studied by high‐ and low‐resolution mass spectrometry

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed: this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Mexedrone article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.